Skip to content
healthcare.dev

SODIUM PHENYLACETATE AND SODIUM BENZOATE

NDC 68382-396, sodium phenylacetate and sodium benzoate, injection, solution, concentrate, from Zydus Pharmaceuticals USA Inc..

Product NDC
68382-396
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205880
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68382-396 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM PHENYLACETATE100 mg/mL
  • SODIUM BENZOATE100 mg/mL

Pharmacologic classes

Ammonium Ion Binding Activity [MoA]; Ammonium Ion Binding Activity [MoA]; Nitrogen Binding Agent [EPC]; Nitrogen Binding Agent [EPC]

Package NDCNDC-11Package
68382-396-01683820396011 VIAL in 1 CARTON (68382-396-01) / 50 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/204e84a7-5440-4537-9e40-06eb56c415e9

Use it

Look up 68382-396 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68382-396 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68382-396. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.